Every SEC Form 3/4/5 on record for this filer (CIK 1653881) — 3 issuers, 44 transactions. Section-16 filings only: what they filed, not a biography, and titles are as filed on their latest form at each issuer.
| Ticker | Company | Role as filed | On file | Forms | Open-market net |
|---|---|---|---|---|---|
| RCUS | Arcus Biosciences, Inc. | Chief Financial Officer | 2020-08-04 → 2026-05-12 | 22 | −$1M |
| UBX | Unity Biotechnology, Inc. | Chief Financial Officer · lapsed | 2018-05-02 → 2020-06-24 | 9 | — |
| CTMX | CytomX Therapeutics, Inc. | Chief Financial Officer · lapsed | 2015-10-07 → 2017-05-16 | 10 | −$426,340 |
| Ticker | Date | Action | Shares | Price | Value | Held after |
|---|---|---|---|---|---|---|
| RCUS | 2026-05-11 | Sell | 7,763 | $25.63 | $198,966 | 84,161 |
| RCUS | 2025-12-31 | Sell | 6,552 | $23.38 | $153,186 | 67,924 |
| RCUS | 2025-12-17 | Sell | 5,960 | $22.16 | $132,074 | 74,476 |
| RCUS | 2025-12-16 | Sell | 6,702 | $21.88 | $146,640 | 80,436 |
| RCUS | 2025-11-26 | Sell | 5,000 | $25.00 | $125,000 | 87,138 |
| RCUS | 2025-10-28 | Sell | 5,000 | $20.00 | $100,000 | 92,138 |
| RCUS | 2024-12-31 | Sell | 3,594 | $15.00 | $53,910 | 60,138 |
2 of 3 issuers are covered and open a security page; the rest are on file here only.
